Our company is ready to help people be happy. We are dedicated to finding and introducing new pharmaceutical products into healthcare practice.
According to our mission, the company’s strategy involves the development of two unique areas:
1. Expand the portfolio of our own medicines. Therefore, we are constantly investing in research and development of new products that can solve one of the most challenging healthcare issues that is called the resistance of microorganisms to antimicrobial drugs.
2. We also consider the possibility to expand our company’s product range with new unique innovative drugs of other pharmaceutical manufacturers.
• AlPharma is going to be a leader in R&D of new anti-infective drugs, and we have a portfolio of drugs with more than 20 unique pharmaceuticals;
• AlPharma is going to maintain its position of the leader in sales of new original anti-infective drugs in the Russian Federation;
• AlPharma is going to become an international pharmaceutical company and export its pharmaceuticals to the countries of the Persian Gulf, Africa, LATAM, ASEAN and other countries, invest in CMO and other forms of cooperation with foreign drug manufacturers.